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The genus Coccolithovirus is a recently discovered group of
viruses that infect the globally important marine calcifying
microalga Emiliania huxleyi. Surprisingly, the viral genome
contains a cluster of putative sphingolipid biosynthetic genes
not found in other viral genus. To address the role of these genes
in viral pathogenesis, the ehv050 gene predicted to encode a
serine palmitoyltransferase (SPT), the first and rate-limiting
enzyme of sphingolipid biosynthesis, was expressed and characterized in Saccharomyces cerevisiae. We show that the encoded
protein is indeed a fully functional, endoplasmic reticulum-localized, single-chain SPT. In eukaryotes SPT is a heterodimer
comprised of long chain base 1 (LCB1) and LCB2 subunits.
Sequence alignment and mutational analysis showed that the
N-terminal domain of the viral protein most closely resembled
the LCB2 subunit and the C-terminal domain most closely
resembled the LCB1 subunit. Regardless of whether the viral
protein was expressed as a single polypeptide or as two independent domains, it exhibited an unusual preference for myristoyl-CoA rather than palmitoyl-CoA. This preference was
reflected by the increased presence of C16-sphingoid bases in
yeast cells expressing the viral protein. The occurrence of a single-chain SPT suggested to us that it might be possible to create
other fusion SPTs with unique properties. Remarkably, when
the two subunits of the yeast SPT were thus expressed, the single-chain chimera was functional and displayed a novel substrate preference. This suggests that expression of other multisubunit membrane proteins as single-chain chimera could
provide a powerful approach to the characterization of integral
membrane proteins.

Sphingolipids are essential structural components of membranes, are enriched in lipid rafts, and have been implicated as
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important second messengers in many signaling processes. In
addition, defects in sphingolipid metabolism are responsible for
a variety of diseases. The enzyme serine palmitoyltransferase
(SPT)2 catalyzes the rate-limiting step of sphingolipid synthesis. In both prokaryotes and eukaryotes the intact enzyme contains two polypeptide chains, and there is no evidence for posttranslational modification of either chain. The prokaryotic
enzyme is a soluble homodimer containing two symmetric
active sites (1). In eukaryotes there is substantial evidence that
the enzyme is an endoplasmic reticular (ER)-localized heterodimer containing a single catalytic site formed at the interface between the subunits (2– 4). It has also been shown that in
addition to its ability to catalyze the condensation of serine with
palmitoyl-CoA, the eukaryotic enzyme can catalyze the condensation of serine with other acyl-CoAs (5). However, despite
the importance of this enzyme, little is known about its structural organization and regulation.
Recently, the sequence of a coccolithoviral genome, EhV-86,
was reported (6). This virus infects the marine algae Emiliania
huxleyi, which plays a significant role in the cycling of carbon in
marine environments and is responsible for large algal blooms
that reflect sunlight and heat and have been proposed to influence global climate. Viral infection results in attenuation of
these blooms and is believed to be important in biogeochemical
cycling in the ocean as well as global climate control (7, 8).
Remarkably, unlike the sequence of any other virus reported to
date, EhV-86 contains a cluster of genes highly homologous to
those which in other systems, from yeast to mammals, have
been shown to encode enzymes of sphingolipid metabolism.
These genes are coordinately expressed within 2 h of infection,
suggesting that their role is to alter algal sphingolipid metabolism (9). A particularly surprising feature of the gene cluster is
the presence of a single open reading frame (ORF), ehv050,
which encodes what appears to be both subunits of a eukaryotic-like SPT. However, the sequence is also homologous to
other ␣-oxoamine synthases not involved in sphingolipid biosynthesis, leaving open the possibility that this gene might
2

The abbreviations used are: SPT, serine palmitoyltransferase; ER, endoplasmic reticulum; HA, hemagglutinin; GFP, green fluorescent protein;
vSPT, EhV-86 virally encoded SPT; LCB, long chain base; PHS, phytosphingosine; DHS, dihydrosphingosine; ORF, open reading frame; YPD,
yeast extract/peptone/dextrose; BisTris, 2-[bis(2-hydroxyethyl)amino]2-(hydroxymethyl)propane-1,3-diol.
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encode an SPT with broad substrate specificity or a new class of
␣-oxoamine synthases capable of catalyzing multiple condensation reactions, including some not involved in sphingolipid
biosynthesis.
Unfortunately, the inability to experimentally manipulate
the genes of the virus or the host makes it difficult to study the
products of the putative sphingolipid gene cluster in the native
organism. Similarly, proving that ehv050 or any other genes in
the cluster are actually involved in sphingolipid synthesis or
that sphingolipids are important in the viral life cycle is also not
possible. To address these questions we have undertaken the
characterization of the putative sphingolipid genes in Saccharomyces cerevisiae. We report that the single-chain SPT-like
EhV-86 enzyme restores SPT activity and viability to yeast
mutants lacking endogenous SPT. We further demonstrate
that, unlike the other characterized SPT enzymes, this virally
encoded enzyme displays a preference for myristoyl-CoA. We
have also expressed both yeast and human SPT as single-chain
fusion proteins and show that they are enzymatically active.
This suggests that other multisubunit membrane-associated
enzymes could be similarly expressed, thus providing a powerful tool for the study membrane proteins.

EXPERIMENTAL PROCEDURES
Yeast Strains, Media, and Growth—Yeast cells were grown
according to standard procedures (10). The yeast strains used
have been described previously (11).
SPT Protein Expression—The ehv050 ORF was PCR-amplified from EhV-86 viral DNA and cloned into the yeast vector
pADH2 under the control of the ADH1 promoter for expression with an N-terminal 3 ⫻ HA tag. The N- and C-terminal
domains of ehv050, tagged with 3 ⫻ HA and Myc, respectively,
were cloned under the control of either the Ga110 (vLCB2) or
the Gal1 (vLCB1) promoter. Briefly, a PCR fragment encoding
the N-terminal domain of vSPT (codons 1– 472) was generated
using the forward primer, 5⬘-AAGGGCGGCCGCTATGTACCCATACGAT, and the reverse primer, 5⬘-TTCCGGATCCATGCGTTTTCTTTGACTC, cleaved with NotI and BamH1(sites
underlined), and inserted between the NotI and BglII sites of
pESC-LEU to generate an HA-tagged vLCB2. A PCR fragment
encoding the C-terminal domain of the vSPT (codons 473– 870)
was generated using the forward primer, 5⬘-AGACCTCGAGTTTCACTCCGATGTT, and the reverse primer, 5⬘-AGGCCAAGCTTATGTACACGGCCGTA), cleaved with XhoI and HindIII
(sites underlined), and inserted between the XhoI and HindIII
sites of the pESC-URA to generate an N-terminal Myc-tagged
vLCB1. For construction of GFP-vSPT, a GFP gene flanked
by XbaI sites was inserted into an AvrII site introduced into
the vSPT gene at codon 2. Intracellular localization was
determined by fluorescence microscopy as previously
described (12). The yeast Lcb2-Lcb1p fusion was made by
fusing the yeast LCB1 gene to the C terminus of the yeast
LCB2 gene such that the fusion protein contained all of
Lcb2p followed by all of Lcb1p except for its N-terminal
methionine. The human fusion protein contained all of
hLCB2 followed by hLCB1 lacking the first 48 amino acids
(hLCB2-LCB1). The human protein was expressed in Ly-B
cells as previously described (12).
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Long-chain Base Extraction and Analysis—Long chain bases
(LCBs) were extracted, derivatized for detection, and resolved
by high performance liquid chromatography according to published procedures (13).
Microsome Preparation, Immunoblotting, and SPT Activity Assays—Yeast and Ly-B microsomal proteins were prepared, resolved using a 4 –12% BisTris NuPAGE gel system
(Invitrogen), and visualized by immunoblotting as previously described using anti-HA (Roche Applied Science),
anti-Myc (Sigma), anti-human LCB1 (Transduction Laboratories), and the previously described yeast anti-LCB1 and
anti-LCB2 antibodies (11). Secondary antibodies were purchased from Bio-Rad. SPT was assayed as described previously (11, 12). The SPT inhibitor myriocin was purchased
from BIOMOL International L.P.

RESULTS
ehv050 Encodes an Active SPT Enzyme—The EhV-86
genome contains an expressed ORF, ehv050, composed of
two tandemly repeated ␣-oxoamine synthase domains.
Alignments revealed the N- and C-terminal domains to be
most closely related to the Lcb2p and Lcb1p subunits,
respectively, of SPT (Fig. 1). In addition to the overall homology, the positions of critical catalytic residues in the two
subunits of SPT are conserved in the two viral domains. The
N-terminal domain of the viral protein contains the lysine
residue present in Lcb2p that forms a Schiff’s base with the
pyridoxal 5⬘-phosphate cofactor, and the C-terminal domain
contains a cysteine in a position analogous to that of the
cysteine residue in Lcb1p that has been proposed to lie
across the subunit interface from the lysine in Lcb2p. This
cysteine is critical for enzymatic activity and when mutated
in human SPTLC1 results in the neurodegenerative disease,
HSAN1 (4, 14, 15). Although the viral protein lacks a region
homologous to the N-terminal extensions of yeast and mammalian LCB1s, in which the first of their three membrane
spanning domains is located, this extension is not present in
other ␣-oxoamine synthases and is not required for enzymatic activity (12). Taken together, these results suggest that
the ehv050 ORF encodes a novel single-chain SPT (vSPT).
To test this hypothesis, the viral gene was expressed in yeast,
and its ability to reverse the LCB requirement of SPT-deficient
yeast mutants was determined. As shown in Fig. 2, expression of
vSPT rescued the LCB requirement of a yeast lcb1⌬ mutant.
This rescue was not dependent upon yeast Lcb2p since the
vSPT also rescued an lcb1⌬lcb2⌬ double mutant. In addition,
mutation of the conserved lysine in the Lcb2p-like N-terminal
domain or mutation of the conserved cysteine in the Lcb1p-like
C-terminal domain resulted in loss of function (data not
shown).
Although expression of vSPT complemented yeast mutants
lacking endogenous SPT activity, growth was generally slower
and showed greater temperature dependence. In particular,
vSPT did not support growth at 37 °C (Fig. 2). In vitro SPT
activity measurements revealed that microsomes prepared
from vSPT-rescued cells contained ⬃1⁄10 as much activity as
microsomes prepared from wild type yeast (Table 1). Yeast lcb1
and lcb2 mutants with reduced SPT activity are temperatureVOLUME 281 • NUMBER 52 • DECEMBER 29, 2006
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FIGURE 1. Ehv050 encodes an 870-amino acid protein composed of tandemly repeated ␣-oxoamine synthase domains. A is an alignment of residues
42– 461 of the viral SPT (CLV) with human (HS), Arabidopsis (At2a and At2b), and yeast (SC) LCB2. The conserved pyridoxal phosphate binding lysine is indicated
with an asterisk (*), and the potential glycosylation sites are indicated by the ƒ. B is an alignment of residues 528 – 804 of the vSPT with human (HS), Arabidopsis
(At1), and yeast (SC) LCB1. The cysteine residue in the glycine motif that lies across the subunit interface from the pyridoxal phosphate binding lysine is marked
with an asterisk (*), and the potential glycosylation sites are indicated by the ƒ.

FIGURE 2. vSPT rescues yeast mutants lacking endogenous SPT. vSPT was
expressed in lcb1⌬ or lcb1⌬tsc3⌬ mutant yeast. Wild type yeast and the indicated mutants were spotted onto YPD plates with or without 15 M PHS and
incubated at the indicated temperatures.

sensitive for growth (16). Similarly, mutants lacking Tsc3p,
which is required for optimal SPT activity in yeast, are also
temperature-sensitive (11). Thus, the inability of vSPT-rescued
DECEMBER 29, 2006 • VOLUME 281 • NUMBER 52

cells to grow at 37 °C is consistent with the requirement for
higher SPT activity at elevated growth temperatures. The activity of vSPT was not further decreased in microsomes prepared
from vSPT-rescued cells lacking Tsc3p, indicating that the
vSPT protein is not activated by Tsc3p.
vSPT Condenses Serine with Myristoyl-CoA More Efficiently than with Palmitoyl-CoA—Although the data presented above are consistent with the interpretation that failure of the vSPT-rescued mutants to grow at a higher
temperature is due to reduced LCB synthesis, they do not
exclude the possibility that the LCBs generated by the vSPT
are different from wild type yeast. Analysis of LCBs in the
vSPT-rescued yeast revealed that there was significantly less
C20-phytosphingosine (C20-PHS) and more C16-dihyJOURNAL OF BIOLOGICAL CHEMISTRY
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C14-CoA was the preferred in vitro substrate. Thus, the
vSPT is distinctly different from its yeast counterpart in substrate preference.
In addition to its homology with the subunits of SPT, there is
significant homology between the viral protein and other members of the ␣-oxoamine synthase family. The greatest homology
was with 5-aminolevulinate synthase, encoded by the yeast
HEM1 gene and which catalyzes the committed step of heme
biosynthesis, the condensation of succinyl-CoA with glycine.
However, vSPT did not complement a hem1 mutant (Fig. 4A).
Moreover, vSPT was sensitive to myriocin, a sphingosine analogue that is a specific and potent inhibitor of yeast and mamTABLE 1
malian SPT (17) (Fig. 4B). Thus, although its substrate specificvSPT prefers C14-CoA as substrate
ity is somewhat different from previously characterized SPTs,
Microsomes were prepared from vSPT-expressing lcb1⌬ and wild type yeast cells,
the viral enzyme is a bona fide SPT that does not appear to have
and SPT activities were assayed using the indicated acyl-CoA substrates. ND, not
determined.
additional activities.
SPT Activity
Structural Plasticity of the vSPT Enzyme—Despite the fact
Acyl-CoA chain length
Viral SPT
Yeast SPT
that the two ␣-oxoamine synthase domains of the ehv050 gene
pmol/mg/min
are contained in a single ORF, it is possible that the protein is
C4
0.10
ND
processed by proteolytic cleavage between the two domains
C8
0.18
ND
into two polypeptides which then assemble into an active headC10
0.57
ND
C12
1.10
37.25
to-tail heterodimer, the structure of all previously characterC14
11.00
91.43
ized eukaryotic SPTs. To address this possibility, extracts preC16
7.73
129.32
C18
2.82
62.42
pared from yeast cells expressing a functional N-terminally
C16:1
1.39
ND
HA-tagged vSPT were analyzed by immunoblotting. A memC18:1
5.25
ND
C18:2
1.31
ND
brane-associated protein of 96 kDa, the predicted molecular
mass for the full-length protein, was
easily detected; there was no evidence for the presence of a shorter
protein that would have resulted
from cleavage between the putative
Lcb2p and Lcb1p domains (Fig. 5A).
Interestingly however, the fulllength protein was resolved into
multiple molecular species, which
were converted to a single molecular weight component upon treatment with endoglycosidase H. This
is consistent with the fact that the
viral protein contains several potential N-linked glycosylation sites (Fig.
1) and suggested that the protein
resides in the ER. The ER localization was confirmed by direct visualization of a GFP-vSPT chimera that
showed a pattern of fluorescence
typical of ER proteins, including the
yeast GFP-Lcb1p (Fig. 5B).
Active SPT could also be reconstituted by separately expressing the
N- and C-terminal domains of the
vSPT; coexpression of the two
domains restored sufficient activity
to rescue the yeast SPT-deficient
FIGURE 3. vSPT-rescued mutants accumulate C16-LCBs. Wild type and the vSPT-rescued lcb1⌬ yeast were mutants (Fig. 6C). In addition, the
grown in YPD, YPD ⫹ 0.1 mM myristate, or YPD ⫹ 1.0 mM myristate for several generations before LCB extrac- reassembled subunits yielded an
tion and analysis as described under “Experimental Procedures.” The peaks corresponding to the 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate-derivatized C16-PHS, C16-DHS, C18-PHS, C18-DHS, and the C17-DHS enzyme with the same preference
for myristoyl-CoA as the full-length
internal standard along with their retention times are indicated. LU, luminescence units.
drosphingosine (C16-DHS) and C16-PHS than in wild type
cells (Fig. 3). The high levels of C16-LCBs are especially
striking in light of the fact that the endogenous concentration of myristate is much lower than the concentration of
palmitate, suggesting that the vSPT has a relative preference
for C14-CoA. Indeed, when cells were grown on myristate,
the relative abundance of C16-LCBs in the vSPT-rescued
cells was even greater (Fig. 3). To more carefully assess the
substrate preference of the vSPT, its ability to catalyze the
condensation of serine with different acyl-CoAs was determined (Table 1). As predicted by the in vivo LCB profiles,
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FIGURE 4. vSPT does not rescue a hem1⌬ mutant and is inhibited by
myriocin. A, wild type (HEM1) or hem1⌬ yeast were transformed with
pADH1 or a vSPT-expressing pADH1 plasmid, and the transformants were
tested for growth on YPD plates with (⫹ALA) or without (⫺ALA) aminolevulinic acid. B, SPT activity was assayed using microsomes prepared from
wild type (yeast SPT) or lcb1⌬ cells expressing vSPT (vSPT) in the presence
of the indicated concentrations of myriocin.

FIGURE 5. vSPT is a single-chain ER-associated protein. A, 10 g of microsomal protein from cells expressing 3 ⫻ HA-vSPT were resolved by SDS-PAGE
before or after treatment with endoglycosidase H (EndoH). vSPT was visualized by immunoblotting as described under “Experimental Procedures.” Loss
of the higher molecular weight form after endoglycosidase H treatment indicates N-glycosylation. B, the intracellular localization of GFP-vSPT and GFPLcb1p was determined by fluorescence microscopy.

protein (Fig. 6D). Thus, the separated domains can reassemble
and fold into an active SPT enzyme with similar properties to
the fusion protein. The data shown in Fig. 6A also suggest that it
is the Lcb2p-like domain that is glycosylated since only this
domain exhibited endoglycosidase H-sensitive heterogeneity.
However, because mutation of the two potential glycosylation
sites in the Lcb2p-like domain of the full-length protein did not
DECEMBER 29, 2006 • VOLUME 281 • NUMBER 52

FIGURE 6. Independently expressed domains of the vSPT reassemble into
an active protein. A and B, microsomes prepared from cells expressing fulllength HA-vSPT (lanes 1 and 2), the HA-tagged N-terminal domain (HA-vLCB2)
of the vSPT (lanes 3 and 4), the Myc-tagged C-terminal domain (Myc-vLCB1) of
vSPT (lanes 5 and 6), or both the N- and C-terminal domains (lanes 7 and 8)
were resolved by SDS-PAGE after treatment with or without endoglycosidase
H (EndoH). The tagged proteins were detected with anti-HA (A) or anti-Myc
(B). The approximate 54-kDa protein seen in all lanes (B) is an anti-Myc crossreactive protein unrelated to vSPT. C, Lcb1⌬ mutant cells expressing fulllength vSPT, vLCB2, vLCB1, or both vLCB2 and vLCB1 were tested for growth
with (left) or without (right) PHS at 26 °C. D, SPT activity was assayed using
microsomes prepared from lcb1⌬ mutant cells expressing full-length vSPT or
vLCB2 and vLCB1 using myristoyl-CoA (C14) or palmitoyl-CoA (C16) as the
acyl-CoA substrates.

abolish all glycosylation (data not shown), glycosylation of the
full-length vSPT is apparently different from that of the separated domains. Analysis of the coexpressed vSPT subunits also
showed that stable expression of the vSPT Lcb2p-like protein
does not depend upon the presence of the vSPT Lcb1p-like
protein (Fig. 6, A and B). This is in sharp contrast to the situation in both yeast and mammals where the stability of monoJOURNAL OF BIOLOGICAL CHEMISTRY
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meric Lcb2p is strictly dependent upon the presence of Lcb1p
(3, 11, 12).
Characterization of a Yeast Single-chain SPT Provides
Additional Evidence for Structural Plasticity of the SPT Enzymes—The discovery of this novel viral fusion SPT enzyme
composed of two separable domains suggested that fusion of
the two subunits of the yeast and other eukaryotic SPTs
would yield active enzymes. To test this possibility, full-length
yeast Lcb1p was fused to the C terminus of Lcb2p to create a
yeast Lcb2-Lcb1p fusion protein. Expression of this fusion protein provided sufficient SPT activity to complement the LCBrequiring phenotype of a yeast lcb1⌬ lcb2⌬ mutant (Fig. 7B).
Unlike the vSPT, the yeast fusion protein was dependent on
Tsc3p for full activity, demonstrating that like the native heterodimer the yeast fusion protein retains its interaction with
Tsc3p. SPT activity assays showed that the yeast Lcb2-Lcb1p
fusion protein, which was expressed to the same extent as the
individual subunits (Fig. 7A), had ⬃30% as much activity as the
native Lcb2p/Lcb1p heterodimer when assayed with C16-CoA
as the substrate (Fig. 7C). However, with C14-CoA as the substrate the activity of the fusion protein was ⬃60% that of the
native enzyme, and with C12-CoA as substrate, the fusion protein and the native protein had equivalent activities. Thus, it
appears that like vSPT, the yeast fusion protein has an altered
substrate preference. In addition, a human hSPTLC2-SPTLC1
fusion protein was active when expressed in a Chinese hamster
ovary cell line lacking endogenous SPT activity (Fig. 7, D and E),
demonstrating that the ability to construct an active SPT chimera is a general property of this protein.
The data presented thus far are consistent with the conclusion that the fusion proteins fold as monomers with single
active sites formed at the interface between the two domains.
However, the possibility that two full-length fusion proteins
associate to form a head-to-tail homodimer, creating an
enzyme with two active sites, cannot be excluded. Two lines of
evidence argue that this is not the case. First, coexpression of a
yeast Lcb2-Lcb1p fusion protein containing an inactivating
mutation at the lysine residue of the Lcb2p domain with a yeast
Lcb2-Lcb1p fusion protein containing an inactivating mutation
at the cysteine residue of the Lcb1p domain did not rescue an
lcb1⌬lcb2⌬ mutant (data not shown). If the active form of the
enzyme were a head-to-tail homodimer, then coexpression of
these mutants should have yielded a population of dimers, 50%
of which contained one active site and one mutated site.
Because of the robust activity of the yeast Lcb2-Lcb1p fusion
protein (40 pmol/mg/min), even this reduced level of activity
should have been sufficient to restore growth. Second, if the

FIGURE 7. Yeast and human fusion SPTs are enzymatically active. A, 10 g
of microsomal protein from wild type yeast cells or cells expressing the yeast
Lcb2-Lcb1p fusion but lacking endogenous Lcb1p, lacking endogenous
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Lcb2p, or lacking both Lcb1p and Lcb2p were fractionated by SDS-PAGE, and
the subunits were visualized by immunoblotting using anti-Lcb1p (left) or
anti-Lcb2p (right). B, yeast lcb1⌬lcb2⌬ (rows 1 and 2) or lcb1⌬lcb2⌬tsc3⌬ (row
3) mutant cells containing empty vector (row 1) or vector expressing yeast
Lcb2-Lcb1p (rows 2 and 3) were assayed for growth at 26 or 37 °C in the
presence or absence of PHS. C, SPT activities in microsomes prepared from
the wild type (WT) and the Lcb2-Lcb1p-rescued lcb1⌬lcb2⌬ mutant (Fusion)
were assayed using acyl-CoA substrates of the indicated chain length. D, Ly-B
Chinese hamster ovary cells (24) were transfected with vector (lane 1),
hSPTLC1 (lane 2), or hSPTLC1-SPTLC2 (lane 3), and the expressed protein was
detected by immunoblotting using anti-hSPTLC1. E, microsomes prepared
from transfected cells were assayed for SPT activity as in C.

VOLUME 281 • NUMBER 52 • DECEMBER 29, 2006
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Lcb1p domain of the yeast Lcb2-Lcb1p fusion protein were able
to associate with the Lcb2p domain of a second fusion protein,
then it should also be able to associate with, and thereby stabilize an Lcb2p monomer. However, the immunoblot clearly
shows that there is no Lcb2p monomer stabilized in the lcb1⌬
mutant expressing the fusion protein (Fig. 7A). Thus, we conclude that the active form of SPT fusion proteins is a folded
monomer.

DISCUSSION
Sequencing of the Coccolithovirus genome identified a putative SPT-encoding gene in which both subunits of the classical
enzyme are contained in a single ORF (6). Similar fusion proteins are found in EST libraries from E. huxleyi,3 and Acanthamoeba histolytica (18). For all three single-chain proteins,
the N-terminal domain most closely resembles the Lcb2p subunit of traditional SPTs, and the C-terminal domain most
closely resembles the Lcb1p subunit. However, in the absence
of genomic sequence from either organism it is unclear that
these are the only SPTs present or how the genes that encode
them are organized. In addition, since the domains of vSPT are
no more homologous to those of the putative SPT from the host
than they are to the individual subunits of yeast, Arabidopsis, or
mammalian SPTs, the phylogenetic relationship between the
viral and host SPT fusion proteins is not apparent.
The unique preference of vSPT for C14-CoA suggests that
during infection it might function as a serine myristoyltransferase. However, because little is known about the sphingolipid
composition of E. huxleyi, it is also possible that there may be as
yet unidentified substrates that are condensed with serine.
Although when measured 24 h after infection, the ratio of C16:
C18 LCBs was greater in infected cells than has been seen in
other organisms, this increased ratio was also observed in uninfected cells. Thus, despite the relatively low homology between
the viral and host enzymes, there is no evidence that this translates into an altered profile of LCBs. Resolution of the question
of whether expression of vSPT and other virally encoded sphingolipid genes alter LCB or complex sphingolipid composition
will require more extensive sphingolipid profiling over the
entire course of EhV-86 infection.
When proteins are found as multidomain “chimera,” it has
been suggested that elsewhere in nature there will be examples
where the individual domains are contained in separate proteins that heterodimerize (19). Thus, the presence of naturally
occurring single-chain and heterodimeric SPTs is not entirely
surprising. Structural plasticity in the ␣-oxoamine synthases
was also suggested by studies on murine erythroid 5-aminolevulinate synthase, a homodimeric ␣-oxamine synthase with significant homology to SPT, which is active in at least three circularly permutated configurations (20 –22). In addition, we
have previously shown that the Lcb1p subunit of yeast and
mammalian SPT can tolerate insertion of a 53-amino acid
domain from yeast invertase at multiple positions without loss
of activity (12). These results led us to consider the possibility
that yeast and/or mammalian SPT, expressed as a single-chain
fusion, would be active. Our results clearly demonstrate that
3
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this is the case. In addition, the yeast fusion protein localizes
to the same intracellular organelle, and its maximum activity
depends on the presence of Tsc3p, indicating that the singlechain protein retains many important properties of the
native heterodimer. A yeast Lcb1-Lcb2p chimera also
showed some activity (data not shown). Thus, an active
enzyme can be formed in at least three different ways, demonstrating a high degree of flexibility in the formation of its
active site. It should be pointed that although the vSPT is not
proteolytically cleaved to distinct domains in yeast, we cannot exclude the possibility that this or other posttranslational modifications that could alter substrate specificity
occur in the algal host. In addition, although there is no Tsc3plike protein encoded within the viral genome, it is possible that
the viral genome encodes a functional ortholog or that the host
expresses such a protein.
One property of the single-chain yeast protein significantly
different from that of the native heterodimer was its relative
preference for shorter chain acyl-CoA substrates. Unlike the
native heterodimer, maximum activity was obtained with C14CoA, and the enzyme was just as active with C12-CoA as with
C16-CoA. Although the altered substrate preference of the single-chain yeast SPT is comparable with the preference of the
viral enzyme, it is not clear to what extent this reflects an intrinsic property of single-chain SPTs since when the viral protein
was expressed as individual domains it retained its preference
for C14-CoAs. Nonetheless, altered preference and high activity of the yeast single-chain protein offers a novel approach for
altering the cellular levels of the shorter LCBs and their metabolic products, including LCB-Ps and ceramides, which have
been implicated in numerous signaling pathways.
It is commonplace to study structure-function relationships
by rearranging protein domains or swapping domains from one
protein to another. In addition, expression of the heterodimeric
gonadotropin hormones as single-chain chimera has allowed
the folding of these hormones to be investigated in great detail
(23). The data presented here demonstrate that the same
approach can be applied to the study of multisubunit membrane-associated proteins. Characterization and purification of
such proteins has proven difficult in part because of subunit
dissociation during solubilization. If, as is the case with SPT,
expression of individual subunits as a single-chain chimera
does not substantively alter the essential properties of the
enzyme, preservation of quaternary structure should be less
difficult. Finally, our results demonstrate that, as has been
shown to be the case for mammalian and plant genes, expression and characterization of novel sphingolipid genes from
marine organisms in appropriate yeast mutants can provide
important insights into the role of these genes in their native
hosts.
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